Replies to post #118598 on PharmaCyte Biotech Inc (PMCB)

[DragonBear]

Professors of Cornell University don’t announce opinions

Neither does their research have anything to do with PMCB.

Ifosfamide is an ineffective drug in 2nd line PC patients.

Their research is checkpoint inhibitors combined with first line drugs, in 1st line patients.